5 assets in Telomere Syndrome

Therapeutic assets addressing Telomere Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Alemtuzumab Telomere Syndrome	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (53)
Cyclophosphamide Telomere Syndrome	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (53)
Fludarabine Telomere Syndrome	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (53)
Melphalan Telomere Syndrome	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (53)
Tacrolimus Telomere Syndrome	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (53)